Manufacturing and Nonclinical Studies Support for the Development of Therapeutic Biotechnology Products (Biologics) for Neurological related Disorders
| SetAside Type | ||
| Solicitation ID | Solicitation Title | Solicitation Office |
| 75N95024R00050 | Manufacturing and Nonclinical Studies Support for the Development of Therapeutic Biotechnology Products (Biologics) for Neurological related Disorders | |
| Synopsis | ||
|
The National Institutes of Neurological Disorders and Stroke (NINDS) has a need for current Good Manufacturing Practices (cGMP) manufacturing and Good Laboratory Practice (GLP) nonclinical (preclinical) support services to support translational development of therapeutic biotechnology products (Biologics) for National Institutes of Health (NIH) drug discovery and development programs. To that end, several NIH programs are being implemented or expanded to provide support for academic and industry investigators developing medical interventions for neurological disorders. This requirement supports the NIH biologics development projects for the NIH Blueprint Neurotherapeutics Network Biologics (BPN-Biologics) program, the NINDS Ultra-Rare Gene Therapy (URGenT) program, the Helping to .... Read More |
||
| Office Location | Agency Name | Solicitation Base Posting Type |
| NATIONAL INSTITUTES OF HEALTH | Combined Synopsis/Solicitation | |
| SetAside Type | ||
| Solicitation ID | Solicitation Title | Solicitation Office |
| 75N95024R00050 | Manufacturing and Nonclinical Studies Support for the Development of Therapeutic Biotechnology Products (Biologics) for Neurological related Disorders | |
| Synopsis | ||
|
Amendment 1: A Question and Response document is posted and the anticipated RFP issue date is postponed to on or after April 15, 2024. Amendment 2: An updated Question and Response document is posted. INTRODUCTION PURSUANT TO FAR Subpart 5.2 – Synopses of Proposed Contract Actions, THIS IS A PRE-SOLICITATION NOTICE OF A PROPOSED CONTRACT ACTION. The National Institute on Drug Abuse (NIDA), Office of Acquisition (OA), on behalf of the National Institutes of Neurological Disorders and Stroke (NINDS), intends to award one or more Indefinite Delivery / Indefinite Quantity (IDIQ) contracts for Manufacturing .... Read More |
||
| Office Location | Agency Name | Solicitation Base Posting Type |
| NATIONAL INSTITUTES OF HEALTH | Presolicitation | |
| SetAside Type | ||
| Solicitation ID | Solicitation Title | Solicitation Office |
| 75N95024R00050 | Manufacturing and Nonclinical Studies Support for the Development of Therapeutic Biotechnology Products (Biologics) for Neurological related Disorders | |
| Synopsis | ||
|
Amendment 1: A Question and Response document is posted and the anticipated RFP issue date is postponed to on or after April 15, 2024. INTRODUCTION PURSUANT TO FAR Subpart 5.2 – Synopses of Proposed Contract Actions, THIS IS A PRE-SOLICITATION NOTICE OF A PROPOSED CONTRACT ACTION. The National Institute on Drug Abuse (NIDA), Office of Acquisition (OA), on behalf of the National Institutes of Neurological Disorders and Stroke (NINDS), intends to award one or more Indefinite Delivery / Indefinite Quantity (IDIQ) contracts for Manufacturing and Nonclinical Studies Support for the Development of Therapeutic Biotechnology Products (Biologics) for .... Read More |
||
| Office Location | Agency Name | Solicitation Base Posting Type |
| NATIONAL INSTITUTES OF HEALTH | Presolicitation | |
